These new medications, like copyright and Semaglutide, represent a important class of drugs called GLP-1 receptor mimics. They work by increasing the body's intrinsic ability to release GLP-1, a chemical that helps regulate blood sugar and food intake. Initially, designed for addressing type 2 diabetes mellitus, they have in addition shown potentia

Semaglutide has gained significant traction here in recent years as a medication for treating type 2 diabetes and obesity. This powerful glucagon-like peptide-1 (GLP-1) receptor agonist works by mimicking the effects of a naturally occurring hormone in the body, promoting blood sugar control . Understanding how semaglutide functions is crucial for